This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
Grants paid by year
Total assets by year
Where the money went · FY2024
Form 990 splits expenses into program services, management and fundraising. The split is self-reported, and a grantmaker, a research institute and a direct-service nonprofit book the same work differently. A line the return does not carry reads "not available"; it is never counted as zero.
| Year | Form | Revenue | Expenses | Grants paid | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2024 | 990 | $47,282,987 | $88,250,427 | $73,252,232 | $299,394,693 | $216,976,767 |
| FY2023 | 990 | $37,742,020 | $61,943,588 | $47,673,524 | $324,173,528 | $259,990,581 |
| FY2022 | 990 | $254,027,105 | $36,842,901 | $29,455,921 | $340,253,841 | $283,512,174 |
| FY2021 | 990 | $53,037,104 | $37,126,176 | $31,052,095 | $116,420,075 | $64,041,673 |
| FY2020 | 990 | $27,631,350 | $28,251,909 | $24,801,068 | $97,381,722 | $49,280,564 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
Recipient focus areas
Where recipients are
Based on the 37% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| OPTINA DIAGNOSTICS | ALZHEIMER'S RESEARCH | $2,135,000 | 2021 | |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Adam Hoffman | GOVERNOR | 1.00 | $0 |
| Alice Shure | GOVERNOR | 1.00 | $0 |
| Ann Jackson | GOVERNOR | 1.00 | $0 |
| Bonnie Englebardt Lautenberg | GOVERNOR |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| ALZHEIMER'S RESEARCH |
| $2,052,000 |
| 2021 |
| IMPERIAL COLLEGE OF LONDON | ALZHEIMER'S RESEARCH | $2,000,000 | 2021 |
| LEXEO THERAPUTICS LLCNEW YORK, NY | ALZHEIMERS RESEARCH | $1,977,336 | 2020 |
| ALZPATH INCCARLSBAD, CA | ALZHEIMERS RESEARCH | $1,910,202 | 2023 |
| BIOLOGICAL DYNAMICSSAN DIEGO, CA | ALZHEIMERS RESEARCH | $1,836,770 | 2020 |
| MINDIMMUNE THERAPEUTICSKINGSTON, RI | ALZHEIMER'S RESEARCH | $1,835,000 | 2021 |
| CLEVELAND CLINIC FOUNDATIONCLEVELAND, OH | ALZHEIMERS RESEARCH | $1,828,343 | 2023 |
| MOLECULAR STETHOSCOPE INCSAN DIEGO, CA | ALZHEIMERS RESEARCH | $1,820,426 | 2022 |
| UNIVERSITY OF ARIZONA - HEALTH SCIENCESTUCSON, AZ | ALZHEIMERS RESEARCH | $1,774,201 | 2024 |
| VACCINEXROCHESTER, NY | ALZHEIMERS RESEARCH | $1,750,000 | 2024 |
| MMS HOLDINGSCANTON, MI | ALZHEIMERS RESEARCH | $1,586,342 | 2022 |
| GAP INNOVATIONS PBCWACHINGTON, DC | ALZHEIMER'S RESEARCH | $1,500,000 | 2021 |
| MTI BIOTECH INCAMES, IA | ALZHEIMERS RESEARCH | $1,450,000 | 2022 |
| FUJIREBIO EUROPE NV | ALZHEIMER'S RESEARCH | $1,442,198 | 2021 |
| VIEWMINDNEW YORK, NY | ALZHEIMERS RESEARCH | $1,429,119 | 2024 |
| MCGILL UNIVERSITY | ALZHEIMER'S RESEARCH | $1,399,078 | 2021 |
| WAVE LIFE SCIENCESCAMBRIDGE, MA | ALZHEIMER'S RESEARCH | $1,190,392 | 2021 |
| MMS HOLDINGSCANTON, MI | ALZHEIMER'S RESEARCH | $1,148,760 | 2021 |
| ASTROCYTE PHARMACEUTICALS INCGROTON, CT | ALZHEIMERS RESEARCH | $1,000,000 | 2023 |
| STARTUP HEALTH LLCNEW YORK, NY | ALZHEIMERS RESEARCH | $975,875 | 2023 |
| KI ELEMENTS | ALZHEIMER'S RESEARCH | $965,827 | 2021 |
| MASSACHUSETTS GENERAL HOSPITALBOSTON, MA | ALZHEIMERS RESEARCH | $963,533 | 2022 |
| VRIJE UNIVERSITEIT AMERSTERDA | ALZHEIMER'S RESEARCH | $855,541 | 2021 |
| TRUSTEES OF BOSTON UNIVERSITYBOSTON, MA | ALZHEIMERS RESEARCH | $844,286 | 2023 |
| 1.00 |
| $0 |
| Bonnie Pfeifer Evans | GOVERNOR | 1.00 | $0 |
| Carol Boulanger | GOVERNOR | 1.00 | $0 |
| David Weinreb | GOVERNOR | 1.00 | $0 |
| Gary M Lauder | GOVERNOR | 1.00 | $0 |
| Henrik Zetterberg Md Phd | GOVERNOR | 1.00 | $0 |
| Howard Fillit Md | FOUNDING EXEC. DIR. & CHIEF SCIENCE OFF. | 40.00 | $663,174 |
| Julieann Shanahan Cfa | GOVERNOR | 1.00 | $0 |
| Lanny Edelsohn Md | GOVERNOR | 1.00 | $0 |
| Laura Steele | GOVERNOR | 1.00 | $0 |
| Laurence Leeds Jr | GOVERNOR | 1.00 | $0 |
| Leonard Lauder | CO-CHAIRMAN /GOVERNOR (DECEASED) | 1.00 | $0 |
| Miia Kivipelto Md Phd | GOVERNOR | 1.00 | $0 |
| Nancy Corzine | GOVERNOR | 1.00 | $0 |
| Nancy Goodes | GOVERNOR | 1.00 | $0 |
| Niranjan Bose Phd | GOVERNOR | 1.00 | $0 |
| Paula Zahn | GOVERNOR | 1.00 | $0 |
| Philip Scheltens Md Phd | GOVERNOR | 1.00 | $0 |
| Rachid Izzar | GOVERNOR | 1.00 | $0 |
| Randal Sandler | CO-VICE CHAIRMAN & SECRETARY | 1.00 | $0 |
| Ric Edelman | GOVERNOR | 1.00 | $0 |
| Richard Mohs Phd | GOVERNOR | 1.00 | $0 |
| Roberta Diaz Brinton Phd | GOVERNOR | 1.00 | $0 |
| Ronald Lauder | CO-CHAIRMAN /GOVERNOR | 1.00 | $0 |
| Sharon Sager | GOVERNOR | 1.00 | $0 |
| Thomas Mcwilliams | CO-VICE CHAIRMAN & TREASURER | 1.00 | $0 |
| Thomas Smith Jr | GOVERNOR | 1.00 | $0 |
| Karen Harris | CFO AND HEAD OF MISSION RELATED INV | 40.00 | $369,039 |
| Mark Roithmayr | CEO | 40.00 | $651,120 |
| Aaron Burstein | HEAD OF SEARCH AND EVALUATION | 40.00 | $314,231 |
| Eli Shobin | SENIOR DIRECTOR DXA | 40.00 | $235,962 |
| Jane Mcintosh | CHIEF EXTERNAL AFFAIRS | 40.00 | $377,792 |
| Lakita Cavin | ATTORNEY, MISSION-RELATED | 40.00 | $220,246 |
| Laura Nisenbaum | EXECUTIVE DIRECTOR, DRUG DEVELOPMENT | 40.00 | $442,772 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990 · FY2023 · period ending Dec 31, 2023IRS bulk XML
Filing id 202423199349312057
Form 990 · FY2022 · period ending Dec 31, 2022
Filing id 202343199349327799
Form 990 · FY2021 · period ending Dec 31, 2021
Filing id 202243199349323979
Form 990 · FY2020 · period ending Dec 31, 2020
Filing id 202200149349300710
Form 990 · FY2019 · period ending Dec 31, 2019
Filing id 202023219349304682
Form 990 · FY2018 · period ending Dec 31, 2018
Filing id 201913189349301946
Form 990 · FY2017 · period ending Dec 31, 2017
Filing id 201823129349302687
Form 990 · FY2016 · period ending Dec 31, 2016
Filing id 201743189349307084
Form 990 · FY2015 · period ending Dec 31, 2015
Filing id 201623209349303432
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.